US-based small molecule medicines provider Innoviva (formerly Advanced Medicine) has announced a private placement of convertible senior notes due 2025 to raise $175m.
Biotechnology company Seattle Genetics plans to acquire biopharmaceutical firm Bristol-Myers Squibb’s pharmaceutical manufacturing facility located in Bothell, Washington, US.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The acquisition will help the company to expand its antibody drug conjugate and immuno-oncology pipeline.
PlasmaGen BioSciences Private has secured $25m through a venture financing round led by Eight Roads Ventures India.
The Indian biopharmaceutical company will use the funds for the expansion of its product portfolio.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
